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Abstract Polymorphisms of AIRE, a transcription factor that up-regulates intrathymic
expression of tissue-specific antigens including melanoma-associated antigens (MAAs), may
variably affect the selection of MAAs-specific thymocytes, generating T-cell repertoires
protecting or predisposing individuals to melanoma. We found that AIRE single nucleotide
polymorphisms (SNPs) rs1055311, rs1800520 and rs1800522 were significantly more frequent in
healthy subjects than in melanoma patients, independently from sex, age and stages of
melanoma. The presence of these SNPs was associated with increased frequency of two T-cell
clonotypes specific for MAGE-1 linking their protective effect to selection/expansion of
MAA-specific T cells. Interestingly, mRNA transcribed on the rs1800520 SNP showed increased
free energy than the wild type suggesting that its reduced stability may be responsible for the
different activity of the polymorphic AIRE molecule. This finding may contribute at identifying
subjects with increased risk of developing melanoma or patients with melanoma that may take
benefit from immunotherapy.
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The AIRE (autoimmune regulator) gene, located in the
21q22.3 region, is approximately 13 kb in length and contains
14 exons that encode a polypeptide of 545 amino acids [1,2].
AIRE protein acts as a powerful transcriptional transacti-
vator [3,4]. In particular, the carboxy-terminal part of AIRE,
containing the plant homeodomain (PHD) finger and leucinevedzipper domain, is supposed to be critical for its transactivation
capacity. Other domains of the AIRE protein indicating its
involvement in transcriptional processes include the amino-
terminal homogeneously staining region (HSR) domain, the
nuclear localization signal (NLS) domain, the SAND domain,
and four LXXLLmotifs [1,2,5]. Since in the Sp100 protein family
the HSR region is responsible for the dimerization of the
polypeptides belonging to these proteins, the HSR domain
present in AIRE is suggested to mediate its homo- or
multidimerization. The SAND domain is thought to act as a
DNA binding domain, and its structure has been determined in
a number of nuclear proteins including Sp100 family proteins
[6,7]. The LXXLL motifs are found in various proteins and are
needed for the binding to nuclear receptors,mainly in a ligand-.
97The role of AIRE polymorphisms in melanomadependent manner [8]. Interestingly, the AIRE PHD1 domain
has also ubiquitin E3 ligase activity. This finding implies that
AIRE might, in addition to its transcriptional regulatory
function, also regulate the intracellular proteosome pathway
[9].
AIRE mutations cause the rare recessive autoimmune
polyendocrinophathy-candidiasis-ectodermal dystrophy syn-
drome (APECED), also known as autoimmune polyendocrine
syndrome-type 1(APS-1). This pathology is a polyglandular
disorder that classically manifests as spontaneous autoim-
munity against the parathyroid and the adrenal glands
associated with mucocutaneous candidiasis infection [10].
Although AIRE is expressed in several tissues, its highest
level of expression is in thymus [11–13] where it is seen in a
subpopulation of medullary thymic epithelial cells (mTEC)
[13]. In mTECs AIRE, binding (directly or indirectly) to
specific motifs in promoter-enhancer regions, or inducing
chromatin remodeling [14], is responsible for the expression
of a large portion of genes known as promiscuously expressed
genes. These genes encode for tissue-restricted self-antigens
(TRAs), proteins that carry out cell type-specific functions,
but which are not necessary for the physiological gene
expression program of thymic stromal cells [15]. The
expression of TRAs in mTECs allows the negative selection
of autoreactive lymphocytes provided with high affinity for
the recognized auto-antigen, but not of those with low/
intermediate affinity [16,17]. This causes the exportation to
the periphery of potentially autoreactive T-cell clones
[18–21]. Although this phenomenon can predispose to the
onset of autoimmunity, it is fundamental for spontaneous or
vaccine-induced generation of anti-cancer immune
responses directed against endogenous tumor-associated
antigens. Hence, a balanced activity of AIRE is necessary
for the immune homeostasis: at variance, hyper-functional
molecular forms of AIRE could expose the individual to an
overwhelming thymocyte deletion depriving the immune
repertoire of clones able to exert irreplaceable effector
activity against cancer cells. Indeed, some melanoma-
associated antigens (MAA), such as MAGE, Gp100, MART-1,
are among TRAs expressed in mTECs [15,22–25]. This
suggests that AIRE polymorphisms impacting on theirFigure 1 Localization of the five polymorphisfunctional activity may condition the thymocyte repertoire
selected on the basis of the recognition of intrathymically
expressed MAAs.
In this study, we selected the five most frequent AIRE
polymorphisms in the European population [rs878081 (C7094T),
rs1055311 (C8385T), rs1800520 (C8723G), rs1800525 (G11107A)
and rs1800522 (T16366C)] (Fig. 1). Their distribution was
analyzed in a series of 70 patients affected with melanoma and
in 171 healthy controls in order to determine their potential
influence on melanoma susceptibility.
Furthermore, the frequency of two MAGE-1-specific
T-cell clonotypes was analyzed in patients carrying less
than two AIRE SNPs in comparison with patients carrying two
or more AIRE SNPs with aim of getting insights on the possible
impact exerted by AIRE polymorphisms on the composition of
the MAA-specific T-cell repertoire.Materials and methods
Patients and controls
Seventy patients affected with melanoma (35 males and 35
females, age ranging from 15 to 75 years, 34 with stage I–II
and 36 with stage III-IV), and 171 healthy control subjects (60
males and 111 females, age ranging from 15 to 75 years)
were analyzed in a case-control study. Diagnosis was based
on typical clinical findings and histological analysis. Periph-
eral blood samples from melanoma patients were collected
immediately after diagnosis and before the beginning of any
treatment. At that moment neither clinical signs of
primitive/secondary hematological or immunological altera-
tions (red cell or leukocyte cytopenias as well as leuko
(lympho)cytosis) nor detectable infectious or autoimmune
diseases were evident.Power calculation
We estimated that a sample size of 70 patients and 140
unmatched controls gives a power of 80% in detecting ams in AIRE gene and AIRE protein domains.
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from 5% to 15% at a significance level of 5%.
Genotyping and polymerase chain reaction (PCR)
product analysis by sequencing
DNA was extracted from the peripheral blood lymphocytes
through proteinase K followed by standard salting-out
technique. The exons of the AIRE gene and its intronic
flanking sequences (GenBank accession no.AB006684) con-
taining the five SNPs were PCR amplified using primers
designed to amplify each of the exons. PCR conditions for the
AIRE gene were optimized using various magnesium concen-
trations and annealing temperatures (Table 1). Genomic DNA
(50 ng) was run in each PCR reaction. PCR products were then
purified from primers by a UltraClean PCR Clean-up Sample
Kit (QIAGEN, Hilden, Germany), automatically sequenced
using the ABI BigDye Terminator Ready Reaction Mix (Applied
Biosystems, Foster City, CA), and analyzed on an ABI 3130XL
Genetic Analyzer (Applied Biosystems, Foster City, CA)
according to the manufacturer's protocol.
DNA sequence analyses were performed on PCR products
amplified using primers specific for the T-cell receptor (TCR)
beta chains of the HLA-Cw*16-restricted, MAGE-1-specific
T-cell clones 81/12 and 26/331 as well as for the HLA-Cw*16
intron 3. Used primers were 5'-CTACAATGAGCAGTTCTTCGG-3'
forward for the complementary determining region (CDR) 3 of
TCR beta chain of anti-MAGE-1 clone 81/12; 5'-CTGGGCACTT-
GAAGCTTTCT-3' forward for the CDR3 of the TCR beta chain of
anti-MAGE-1 clone 26/331; 5'-ACAGCGACCTCGGGTGGGAA-3'
reverse for constant region 2 (Cβ2) of the TCR beta chain of
anti-MAGE-1 clone 81/12; 5'-CCTGGGTCCACTCGT-
CATTCTCCG-3' reverse for constant region 1 (Cβ1) of the TCR
beta chain of anti-MAGE-1 clone 26/331; 5'-AGGCCGGGTCT-
CACACCCTCCA-3' forward for HLA-Cw*16 intron 3;
5'-GTTCTCCAGGTATCTGCGGA-3' reverse for HLA-Cw*16 intron
3 [26]. The parameters used for amplification were 34 cycles
at 94 °C for 30 s, 60 °C for 30 s and 72 °C for 60 s.
Genotyping by real-time PCR
The polymorphism rs1800520 (C8723G) was investigated
using the allelic discrimination assay by real time PCR. An
assay detecting melting differences of a probe with the
rs1800520 SNP and its corresponding wild-type sequence was
utilized in this study. Melting differences were detected
using a FRET hybridization quenching assay [27]. PCR was
performed using two primers flanking the SNP and two
Hybprobes: the 5' located sensor probe, covering the SNP,
and the 3' located anchor probe. The sensor probe wasTable 1 Primer sequences and PCR conditions.





14 GGCCTACACGACTGCCAAGGCAG GTGCACCCGAGTTCdesigned as a perfect match to the polymorphic allele while
the anchor probe was matched to the non-polymorphic
sequence immediately 3' flanking the SNP region. PCR
conditions, primers and Hybprobes specific for the
rs1800520 polymorphism were optimized and purchased
from TIBmolbiol: forward 5'-CCTTGCAGGGTAGAGGT-
GAAGCTA-3', reverse 5'-TATTACCATTGCGTATTATCAGG-3',
Hybprobe Anchor 5'-GGGTCACTGGGGAGGGCCAGAGG FL-3',
Hybprobe Sensor G mut 5'-GCGGGAACCCTGCCCTG PH-3'. The
assay was conducted with the LightCycler instrument (Roche
Diagnostics) and the software 3 Run version 3.5 was used to
analyse probes hybridization and their melting temperature.
Ten nanograms of genomic DNA (max 5 µl) was used per
assay. PCR was carried out in three steps: activation (95 °C
for 8 min), amplification (95 °C for 5 min, 60 °C for 5 min,
72 °C for 15 min), melting (72 °C for 30 s, 95 °C for 20 s,
40 °C for 30 s, 85 °C for 1 min, 40 °C for 5 min). At least 8% of
all genotyping results including all rare heterozygous
genotypes were confirmed by sequencing as described
above. Twenty microliters of the PCR reactions was used in
these experiments with 5 µl of 2× master mix, 0.4 µM of
primers, 0.4 µM of sensor and anchor probes 3 mM MgCl2
(Roche Diagnostics).Quantitative analysis of TCR clonotypes by DNA
amplification through real-time PCR
The analyses were performed on genomic DNA from single
patients bearing 0-1 or 2-3 polymorphic alleles. Twenty
nanograms of genomic DNA, 14.4 µl of nuclease-free water
(Roche Diagnostics), 2 µl of SYBR Green PCR Master Mix (2X)
(Roche Diagnostics), 1.5 mM MgCl2, and 0.5 µM of forward
and reverse primers (described in the “Genotyping and PCR
product analysis by sequencing” section) specific for anti-
MAGE-1 clones 81/12 or 26/331 were mixed in a total 20 µl
volume. Real-time PCRs were performed using the Light-
Cycler instrument (Roche Diagnostics) and SYBR Green
fluorescence intensity of DNA samples was analyzed by the
software 3 Run (version 3.5) (Roche Diagnostics).
Cycling parameters were as follows: an initial incubation
of 10 min at 95 °C to activate the DNA polymerase, then
40 cycles of 15 s at 95 °C followed by 1 min at 60 °C.
Dissociation curves were generated by incubating the
amplicons at 95 °C for 5 s, reducing the temperature to
60 °C for 15 s and increasing the temperature to 95 °C over a
dissociation time of 20 min. Data were analyzed with the
LightCycler software to estimate cycle threshold (Ct) values
and dissociation curves as well as to confirm the presence of
amplicons from TCR beta chain transcripts and their purity.









99The role of AIRE polymorphisms in melanomaequals the threshold level, which is automatically set to be
within the exponential region of the amplification curve
where there is a linear relationship between the log of
change in fluorescence and cycle number. Dissociation
curves are formed plotting rising temperature versus the
change in fluorescence/change in temperature [28].
Prediction of RNA secondary structures of AIRE
allelic variants
The potential variations in folding of the RNA secondary
structure caused by the synonymous and the non-synony-
mous mutation of AIRE variants were identified using the
Vienna RNA package software [29,31].
Statistical analysis
Statistically significant differences between genotype as
well as T-cell clonotype frequencies were assessed using
univariate analyses such as the Fisher's exact test for binary
variables and the Student t test for continuous variables. The
association between the presence of polymorphic genotypes
and independent variables was studied using a multivariate
logistic regression analysis. Odds ratio (ORs) and 95%
confidence intervals (95% CIs) were calculated and P values
lower than 0.05 were considered statistically significant.
Analyses were performed using SPSS 13.0 and Graphpad
Prism 4 softwares.
Results
Reduced frequency of rs1055311 (C8385T),
rs1800520 (C8723G) and rs1800522 (T16366C) SNPs
in melanoma patients compared with controls
The frequencies of five SNPs of AIRE gene, consisting in the
non-synonymous rs1800520 (C8723G) in exon 7, the silentTable 2 Comparison of the frequency of rs878081 (C7094T), rs105




















a In the univariate analysis, the frequencies in controls and patients
b In themultivariate analysis, the comparison between the frequency o
all the SNPs together.mutations rs878081 (C7094T) in exon 5, rs1055311 (C8385T)
in exon 6, rs1800522 (T16366C) in exon 14 and the intronic
SNP rs1800525 (G11107A) in intron 9, were analyzed in both
patient and control groups.
Concerning nucleotide positions 8385 in exon 6
(rs1055311), 8723 in exon 7 (rs1800520) and 16366 in exon
14 (rs1800522), the corresponding heterozygous genotypes
and the homozygous variant genotypes were (C/T) and
(T/T), (C/G) and (G/G), (T/C) and (C/C), respectively. For
each SNP, the heterozygous genotype and the homozygous
variant genotype, collectively considered, were less fre-
quent in melanoma patients than in healthy controls (OR 0.5
95%, CI, 0.2–0.9; P=0.03 for rs1055311, OR of 0.3, 95% CI,
0.1–0.6; P=0.004 for rs1800520, OR of 0.5, 95% CI, 0.3–0.9;
P=0.04 for rs1800522, respectively). No statistically signif-
icant differences between patients and controls were
detected comparing the frequencies of rs878081 SNP in
exon 5 and rs1800525 SNP in intron 9. Detailed results of all
the analyses are reported in Table 2.
Stratification of the frequencies of rs1055311
(C8385T), rs1800520 (C8723G) and rs1800522
(T16366C) SNPs for age, sex and melanoma stage
In order to verify the dependency of the frequencies of
rs1055311 (C8385T), rs1800520 (C8723G) and rs1800522
(T16366C) SNPs on independent variables such as age, sex
and melanoma stage, univariate and multivariate analyses
were performed on the total population of patients and
controls. The frequency of rs1055311 (C8385T) SNP was
found significantly increased in males than in females (O.
R.1.9, C.I. 95% 1.0–3.3; P=0.02), while the opposite was
observed concerning the rs1800520 (C8723G) SNP (O.R. 0.3,
C.I. 95% 0.1–0.7; P=0.006). No statistically significant
differences were detected relatively to rs1800522
(T16366C) SNP, and no significant associations of tested
SNPs with either age or melanoma stage were detected (not
shown).5311 (C8385T), rs1800520 (C8723G), rs1800525 (G11107A) and
ls.
analysis a Multivariate analysis b
P OR (95%CI) P
/0.8 (0.4–1.4) 0.5 1 Reference/0.7 (0.3–1.2) 0.2
/0.5 (0.2–0.9) 0.03 1 Reference/0.4 (0.2–0.9) 0.02
/0.3 (0.1–0.6) 0.004 1 Reference/0.3 (0.1–0.6) 0.004
/0.7 (0.4–1.5) 0.4 1 Reference/0.7 (0.3–1.4) 0.3
/0.5 (0.3–0.9) 0.043 1 Reference/0.5 (0.3–0.9) 0.048
were compared considering each single SNP.
f variant genotypes for each gene regionwas performed considering
Figure 2 Frequency of genotypes with 0-1 or 2-3 of the
rs1055311, rs1800520 and rs1800522 SNPs in melanoma patients
(black bars) and healthy controls (open bars).
100 G. Conteduca et al.Frequencies of different associations of rs1055311
(C8385T), rs1800520 (C8723G) and rs1800522
(T16366C) SNPs in the genotypes of patient and
control groups
Here we define as CCT (wild-type) genotype the one that is
present in subjects who do not carry any of the three
rs1055311, rs1800520 and rs1800522 AIRE gene SNPs. The
frequency of CCT genotype was significantly higher in
subjects with melanoma (18.5%) than in healthy individuals
(8.7%, P=0.05). No statistically significant differences
between patients and controls were found when all the
other possible genotype combinations were considered
(Table 3). Accordingly, when the number of borne poly-
morphisms per subject was considered, individuals with
more than one SNP were significantly more frequent in the
group of healthy controls compared with melanoma patient
group (Pb0.01) (Fig. 2).
Polymorphic AIRE mRNAs structure analysis
Genetic polymorphisms, through nucleotide substitutions,
may generate mRNA molecules showing different secondary
structures. Interestingly, variants of mRNA secondary struc-
ture have been associated with different efficiencies of gene
expression depending on the free energy possessed by the
single mRNA molecule [30]. Hence, we decided to analyze the
impact on mRNA folding of synonymous and non-synonymous
mutations constituting the fiveAIRE SNPs using a computerized
modeling analysis. mRNA endowing allelic variants relative to
synonymous mutations, consisting in the rs878081 (C7094T),
rs1055311 (C8385T) and rs1800522 (T16366C) polymorphisms,
showed equivalent free energy, comparable to that of the
wild-type genotype (dG≈−574,7 kcal/mol), thus excluding
their capacity of generating AIRE mRNA molecules with
secondary structure different from that transcribed on the
wild-type genotype.
We also investigated the mRNA folding structure
corresponding to the AIRE allelic non-synonymous variants
AGCG, present in the wild-type genotype, and AGGG, present
in the rs 1800520 (C8723G) SNP, in exon 7. mRNA transcribed
on AIRE AGCG allele showed lower free energy (dG=−
574,7 kcal/mol) than the one transcribed on the AGGG allele
(dG=−562.6 kcal/mol), suggesting that the former likely has
greater molecular stability than the latter (Fig. 3). Therefore,Table 3 Frequencies of AIRE genotype combinations in
melanoma patients and controls.
Genotype combinations Allelic frequency P
Patients Controls
8385T 8723G 16366C: TGC 0 0.03 0.9
8385T 8723G 16366T: TGT 0 0.01 0.9
8385T 8723C 16366T: TCT 0.05 0.04 0.6
8385C 8723C 16366T: CCT 0.18 0.08 0.05
8385T 8723C 16366C: TCC 0.035 0.06 0.4
8385C 8723G 16366C: CGC 0.028 0.05 0.2
8385C 8723G 16366T: CGT 0.007 0.02 0.2
8385C 8723C 16366C: CCC 0.15 0.1 0.2mRNAmolecules transcribed on AIRE AGCG allele might have a
longer half-life and produce more AIRE protein than mRNA
molecules transcribed on the variant AGGG genotype.
Quantitation of genomic sequences specific for 81/12
and 26/331 T-cell clonotypes
Previous studies reported increased frequency of MAAs-
specific T-cell clonotypes in melanoma patients with
selected HLA haplotypes [26,32,33]. In particular, T-cell
clonotypes 81/12 (carrying TCR beta chain regions V5J2S1C2)
and 26/331 (carrying TCR beta chain regions V5J1S1C1) were
found expanded in HLA-Cw*16 positive melanoma patients
[26]. In order to verify whether T-cell clonotypes 81/12 and
26/331 were differently represented in the T-cell repertoire
of melanoma patients with different AIRE genotypes, we
initially screened our series of patients for the presence of
the HLA-Cw*16 allele. PCR analysis demonstrated that 45 out
of 70 patients were positive for the allele of interest. HLA-
Cw*16 positive patients were subsequently divided in two
groups: group A including subjects carrying the wild-type
genotype or carrying only one protective SNP; group B
including individuals carrying more than one SNP. Genomic
DNA from each patient was amplified by RT-PCR until the
threshold value. Two ranges of cycle numbers that needed to
reach the threshold value were considered for each
clonotype: 30-33 and 34-36 for clonotype 81/12, and 26-29
and 30-31 for clonotype 26/331. Considering clonotype 81/
12, DNA amplification reached the threshold value in the
early (30–33 cycles) range of cycle number in the 91% of
group B patients but only in the 14% of group A patients
(P=0.001). Considering clonotype 26/331, DNA amplification
reached the threshold value in the early (26–29 cycles) range
of cycle number in the 89% of group B patients but only in the
20% of group A patients (P=0.05) (Fig. 4). Hence, these data
unveil an overrepresentation of both T-cell clonotypes in
patients with 2 or more AIRE SNPs with respect to patients
with wild-type genotype or only one SNP.Discussion
The results of this study show that (a) AIRE SNPs rs1055311
(C8385T), rs1800520 (C8723G), and rs1800522 (T16366C) are
Figure 3 Computerized modeling of AIRE mRNA structures of two haplotype variants in exon7. (a) AGCG allelic variant
corresponding to the wild-type genotype; (b) AGGG allelic variant corresponding to the C8723G SNP.
101The role of AIRE polymorphisms in melanomamore frequent in the healthy population than in patients
with melanoma; (b) the free energy of the mRNA transcribed
on AIRE rs1800520 (C8723G) SNP gene sequence is higher
than that of the mRNA transcribed on the corresponding
wild-type genotype; and (c) two MAGE-1-specific T-cell
clonotypes were found more represented in patients with
two or more AIRE SNPs than in those with less than two AIRE
SNPs.
AIRE induces the transcription of tissue-associated antigens
in mTECs, which is important for the negative selection of
autologous cytolytic T lymphocytes (CTL) that recognizeautoantigens. Polymorphic AIRE molecules may differently
regulate selection of thymocytes potentially able to recognize
MAAs once malignant melanoma cells should appear in the
organism. On this basis, we decided to analyze SNPs of AIRE
gene in order to verify whether peculiar polymorphic
genotypes could protect or predispose to the development of
melanoma. Among all the AIRE SNPs already identified, five
SNPs were selected following two main criteria consisting in
their presence at elevated frequency in the European
population (rs878081, rs1055311, rs1800520, rs1800525 and
rs1800522) [34] and in the already demonstrated association
Figure 4 Quantitation of genomic sequences specific for T-cell clonotype 81/12 and 26/331 in HLA-Cw*16 positive patients. Early
and late ranges of cycle numbers of DNA amplification until threshold value were 30-33 and 34-36 cycles for clonotype 81/12 and 26-29
and 30-33 for clonotype 26/331. Data are expressed as percentages of patients in whom the threshold value was reached in one
specific range (early or late) of cycle numbers of DNA amplification. Panels a and b refer to T-cell clonotype 81/12; panels c and d refer
to T-cell clonotype 26/331. Panels a and c refer to the early range of cycle number of DNA amplification; panels b and d refer to late
ranges of cycle numbers of DNA amplification. Open bars: patients carrying the wild-type genotype or only one protective SNP; black
bars: patients carrying more than one SNP.
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linked to alopecia aerata and systemic sclerosis associated
with autoimmune thyroiditis, respectively) [35,36]. Indeed,
we reasoned that an AIRE polymorphic genotype potentially
predisposing to an autoimmune disease could also be
responsible for a lower level of TRAs transcription in the
thymus, including that of tumor-specific antigens, subse-
quently resulting in a less effective negative selection of
autoantigen (and tumor antigen)-specific T lymphocytes and
to a potentially lower susceptibility to tumor development.
Accordingly, recent studies reported that the expression levels
of AIRE and TRAs in mTECs vary considerably from person to
person and that mRNA levels of some TRAs are closely
correlated to those of AIRE itself [37]. Thus, AIRE genetic
polymorphisms cause interindividual variability of AIRE-regu-
lated transcriptional programs in mTECs affecting the levels
and fine specificity of ectopic transcripts [38,39]. Hence,
opposite differences in tissue-specific antigen expression
might result either in escaping of high-avidity antigen-specific
T cells (in the case of low intrathymic TRAs expression) or in
depleting the T-cell repertoire of clones specific for single
(auto)antigens (in the case of elevated intrathymic expression
of the corresponding TRA). Remarkably, a direct gene dosage
effect between the level of antigen expression, the degree of
T-cell deletion/tolerance and the incidence of autoimmunity
has been observed in certain experimental models, thus
showing the relevance of AIRE-dependent fine regulation of
tissue-specific antigen expression [40–44]. Studies performed
in T-cell receptor (TCR) transgenic mice have established that
the efficiency of negative selection depends on TCR avidity
and on the dose-dependent intrathymic self-antigen expres-
sion [45–49]. Our data showing the increased representation of
specific AIRE SNPs in healthy subjects with respect to
melanoma patients suggest that these polymorphisms may
be associated with a reduced intrathymic expression of
melanoma-associated antigens in individuals bearing thecorresponding genotypes, thus conferring them a potential
protection against tumor development. Studies are already
ongoing in our laboratory aimed at verifying whether AIRE
inhibition in mTECs leads to reduced expression of melanoma-
associated antigens.
In the attempt of characterizing at the molecular level the
mechanisms determining the different functional activity of
AIRE allelic variants, we focused our analysis on mRNA folding
structure. Various studies in Escherichia coli and in Drosophila
have shown that there is a selective translation of the
synonymous codons that stabilize the mRNA structure, thus
rendering the mRNA molecule more resistant to degradation
[50]. Accordingly, codon bias might result from selection in
favor of mRNAs with lower folding free energies [51].
Furthermore, additional evidences demonstrate that small
stretches of stem-loops in mRNA structure induced by
nucleotide substitutions are important for the formation of
stable elongation complexes as well as for termination of
transcription: therefore this observation confirms that nucle-
otide substitutions could influence mRNA stability and
regulation of gene expression [52,53]. Our in silico analysis
of the folding of the polymorphic AIREmRNAstructures showed
that the genotype corresponding to rs1800520 SNP leads to the
transcription of amRNAmoleculewhose secondary structure is
likely more unstable than the one of the mRNA coded by the
AIRE wild-type genotype, being provided with higher free
energy. This observation suggests that, in the case of
rs1800520 SNP, AIREmRNAmay have a shorter half life causing
reduced AIRE protein production and, thereby, leading to
lower melanoma-associated antigen expression in mTECs.
Functional studies are ongoing to test this hypothesis.
Other than at the translation level, rs1800520 (C8723G)
polymorphism may condition AIRE function at the protein
level. In fact, it determines the amino acid change S278R in the
SAND domain of the AIRE protein. This domain is responsible
for AIRE binding to DNA [54] and for the nuclear localization of
103The role of AIRE polymorphisms in melanomaAIRE [55,56]. Therefore, mutations at this domain could
destabilize the binding of AIRE toTRAspromoter, thus lowering
TRAs expression in thymic epithelial cells.
Whatever the mechanism involved in AIRE modulation of
TRAs, the immunological outcome of AIRE function should
impact on T-cell repertoire. Considering the case of AIRE-
regulated MAA intrathymic expression, different AIRE geno-
types should induce variable representations of MAA-specific
T-cell clonotypes. In order to test this hypothesis and to
identify an immunological mechanism likely linking expression
of specific AIRE genotypes to their protective activity against
melanoma development, the frequency of two MAGE-1-
specific T-cell clonotypes (81/12 and 26/331) was analyzed
in patients with less than two AIRE SNPs in comparison with
patients carrying two or more AIRE SNPs. The finding that both
T-cell clonotypes were more represented in patients with two
or more protective AIRE SNPs suggests that these polymorph-
isms apply a lower selective pressure on MAAs-specific
thymocytes than wild-type AIRE gene, leading to a peripheral
T-cell repertoire more replenished with MAA-specific T-cell
clones. In order to validate this hypothesis, studies will be
performed taking into consideration a wider panel of MAAs.
In conclusion, our findings indicate that the variant alleles
rs1055311 (C8385T) in exon 6, rs1800520 (C8723G) in exon 7
and rs1800522 (T16366C) in exon 14 exert a significant
protective effect against melanoma (Tables 2 and 3). The
screening for detecting these polymorphisms in the general
population may be useful for identifying subjects with a
higher risk of developing the disease being negative for the
reported polymorphisms. Moreover, in the context of
melanoma patients, the analysis of these polymorphisms
could identify the patients who could better benefit from
immunotherapy because of presenting the cited polymorph-
isms and likely possessing a T lymphocyte repertoire covering
melanoma-specific antigens. Further studies are warranted
to validate these results and to investigate the underlying
molecular mechanisms.
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